EMC China Lab

ISO 10993 Thrombogenicity Test Laboratory

Views :
Update time : 2024-06-08

1 Thrombogenicity Test Introduction

Thrombosis generally occurs in vivo or semi-vivo. When medical devices/materials come into contact with human blood, the surface of the materials may cause plasma proteins such as albumin to adhere. The adhered protein layer will activate the coagulation pathway and cause platelet adhesion, forming fibrin and platelet thrombi respectively, which will promote each other and finally form mural thrombi. Therefore, the medical devices/materials are implanted into the cardiovascular system of dogs through appropriate procedures. After a certain period of time, the thrombosis formation on the surface of the materials and in the blood vessels is observed. This can comprehensively reflect the adhesion of the medical devices/materials to proteins in the blood, the activation of the coagulation pathway and the induction of platelet adhesion, thereby judging the thrombosis risk of the medical devices/materials, scoring the degree of thrombosis on the surface of the materials and in the blood vessels, and comparing the differences between the scores of the test samples and the control samples.

ISO 10993 Thrombogenicity Test Laboratory(图1)

2. Thrombogenicity Test standards

2.1 ISO 10993-4 Biological evaluation of medical devices – Part 4: Selection of tests for interactions with blood;

2.2 GB/T16886.4 Biological evaluation of medical devices – Part 4: Selection of tests for interaction with blood.


3. Thrombogenicity Test system

2 beagles.


4. Thrombogenicity Test samples

In order to ensure sufficient contact between the test sample and the blood, the test sample and control with a length of 15 cm should be selected for intravascular implantation. Depending on the shape and structure of the device, it may be necessary to create a customized device to reduce the length of the component while maintaining the same material ratio as the complete device. If necessary, the device can be subdivided into multiple test samples for testing.


5. Test steps

Figure 1 shows the most commonly used implantation sites for dog intravascular thrombosis testing. It is generally believed that venous implantation is a relatively poor situation and is more likely to form thrombosis. If the product is used in an artery, it can be implanted in the artery for testing. Figure 2 shows the second most commonly used implantation sites for dog intravascular thrombosis. If the shape and size of the sample cannot be implanted in the femoral vein and jugular vein to complete the test, the site in Figure 2 can be selected for testing. For example, vena cava filters can be tested by selecting 1 and 2 in Figure 2.

ISO 10993 Thrombogenicity Test Laboratory(图2)

                   Figure 1. Main implantation sites for canine intravascular thrombosis test (1: femoral vein; 2: jugular vein)

ISO 10993 Thrombogenicity Test Laboratory(图3)


Figure 2. The most commonly used implantation sites in canine intravascular thrombosis testing

(1: inferior vena cava-inferior vena cava; 2: superior vena cava-inferior vena cava; 3: inferior vena cava-abdominal aorta)

The recommended implantation time is greater than 4 hours. If the device is used for no more than 4 hours, the implantation time can be shortened according to the actual use time of the device, or a longer implantation time can be selected according to the use time of the product.


6. Result evaluation

The scoring results of intravascular thrombosis are not statistically analyzed. The difference between the test sample and the control sample is evaluated based on the score, and the score of the test sample should be ≤ the control sample. At the same time, the acceptable scoring results are comprehensively considered based on the clinical use characteristics of the product, and the results of preclinical animal studies and clinical trials can also be comprehensively evaluated. The scoring table is shown in Table 1 and Table 2.
                                                                                                                      Table 1. Thrombosis scoring scheme A

Thrombosis score description

score

No obvious thrombosis

(A very small clot at the insertion site is acceptable)

0

Minimal thrombosis, one

1

Minimal thrombosis, one

2

Significant thrombosis, >1/4 but ≤1/2 of the implant surface,

Vascular patency

3

Obvious thrombosis, >1/2 implant surface, vascular patency

4

Complete occlusion of blood vessels

5


 Table 2. Thrombosis scoring scheme B

Thrombosis score description

score

Thrombus is absent or minimal.

If present, appears to be related to the implant phlebotomy site

0

The thrombus was extremely small, covering 1% to 25% of the material surface.

1

Moderate thrombus, observed to cover 26% to 50% of the material surface

2

Severe thrombosis was observed, covering 51% to 75% of the material surface

3

The thrombus was extensive, covering 76% to 100% of the material surface.

4



Email:hello@jjrlab.com


Leave Your Message


Write your message here and send it to us


Related News
Read More >>
ISO 10993-5 Tests for In Vitro Cytotoxicity ISO 10993-5 Tests for In Vitro Cytotoxicity
04 .03.2025
ISO 10993-5 in vitro cytotoxicity testing evaluates the toxicity of medical devices and biomaterials...
FDA Designated Cytotoxicity Testing Laboratory FDA Designated Cytotoxicity Testing Laboratory
04 .03.2025
FDA-designated cytotoxicity testing lab, JJR China, offers FDA-compliant biocompatibility testing wi...
Cytotoxicity Testing Labs Cytotoxicity Testing Labs
04 .03.2025
Cytotoxicity testing ensures medical device safety. JJR Lab provides compliant certification, meetin...
Introduction to UL94 Flammability Testing Introduction to UL94 Flammability Testing
04 .03.2025
UL94 is a key plastic flammability test for safety and compliance in electronics, automotive, and mo...
Canada Electrical Product Compliance Certification Canada Electrical Product Compliance Certification
04 .03.2025
JJR Lab tests electrical products for compliance with Canadian standards (CSA C22.2/UL), ensuring th...
Button Battery 16 CFR Part 1263 and ANSI/UL 4200A Button Battery 16 CFR Part 1263 and ANSI/UL 4200A
04 .03.2025
Button and coin batteries, and products containing them, must comply with 16 CFR Part 1263 and ANSI/...
American Certification Testing for Baby Walkers American Certification Testing for Baby Walkers
04 .02.2025
JJR Laboratory provides U.S. certification testing for baby walkers, covering design, safety, stabil...
Baby and Children's Products EU & US Certifica Baby and Children's Products EU & US Certifica
04 .02.2025
JJR Laboratory provides EU & US certification testing for baby and children‘s products, ensuring...

Leave Your Message